Bernard L. Schneider

12.4k total citations · 2 hit papers
150 papers, 8.9k citations indexed

About

Bernard L. Schneider is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bernard L. Schneider has authored 150 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 53 papers in Neurology and 51 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bernard L. Schneider's work include Parkinson's Disease Mechanisms and Treatments (37 papers), Nerve injury and regeneration (26 papers) and Virus-based gene therapy research (15 papers). Bernard L. Schneider is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (37 papers), Nerve injury and regeneration (26 papers) and Virus-based gene therapy research (15 papers). Bernard L. Schneider collaborates with scholars based in Switzerland, United States and France. Bernard L. Schneider's co-authors include Patrick Aebischer, Christophe Lo Bianco, Nicole Déglon, Philippe Coune, Hilal A. Lashuel, Takeshi Iwatsubo, Ali Sajadi, Graham Knott, Darren J. Moore and Carine Ciron and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Bernard L. Schneider

145 papers receiving 8.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

2012 450 citations Philippe Coune, Bernard L. Schneider et al. profile →
In Vivo Evidence for a Lactate Gradient from Astrocytes to Neurons

2015 424 citations Bernard L. Schneider, Patrick Aebischer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard L. Schneider Switzerland	54	3.5k	3.2k	2.9k	1.7k	1.2k	150	8.9k
Asa Abeliovich United States	30	4.1k 1.2×	3.6k 1.1×	3.4k 1.2×	1.6k 0.9×	1.1k 1.0×	46	8.4k
Richard Wade‐Martins United Kingdom	55	4.4k 1.3×	3.1k 1.0×	4.6k 1.6×	2.5k 1.5×	908 0.8×	161	10.5k
Veerle Baekelandt Belgium	58	5.3k 1.5×	3.4k 1.0×	4.7k 1.6×	2.7k 1.6×	1.1k 1.0×	218	11.7k
Akiyoshi Kakita Japan	56	4.2k 1.2×	3.0k 0.9×	5.4k 1.8×	2.2k 1.3×	677 0.6×	439	12.3k
Yaping Chu United States	39	2.8k 0.8×	4.1k 1.3×	4.1k 1.4×	1.7k 1.0×	440 0.4×	70	8.2k
Thomas H. Gillingwater United Kingdom	55	5.6k 1.6×	2.3k 0.7×	1.8k 0.6×	1.2k 0.7×	978 0.8×	183	9.6k
Georg Auburger Germany	53	6.5k 1.9×	6.1k 1.9×	4.4k 1.5×	1.1k 0.6×	707 0.6×	194	11.1k
Chris Van den Haute Belgium	45	3.0k 0.9×	2.1k 0.7×	2.3k 0.8×	2.5k 1.5×	543 0.5×	120	7.1k
Antonella Consiglio Italy	31	4.9k 1.4×	2.5k 0.8×	1.8k 0.6×	1.8k 1.0×	705 0.6×	57	8.9k
Vladimir L. Buchman United Kingdom	44	3.1k 0.9×	3.1k 1.0×	3.9k 1.3×	1.8k 1.0×	1.1k 0.9×	142	8.1k

Countries citing papers authored by Bernard L. Schneider

Since Specialization

Citations

This map shows the geographic impact of Bernard L. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard L. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard L. Schneider more than expected).

Fields of papers citing papers by Bernard L. Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard L. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard L. Schneider. The network helps show where Bernard L. Schneider may publish in the future.

Co-authorship network of co-authors of Bernard L. Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard L. Schneider. A scholar is included among the top collaborators of Bernard L. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard L. Schneider. Bernard L. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tahedl, Marlene, Mary C. McKenna, Siobhán Hutchinson, et al.. (2025). Cerebellar dysfunction in frontotemporal dementia: intra-cerebellar pathology and cerebellar network degeneration. Journal of Neurology. 272(4). 289–289. 1 indexed citations

Skinnider, Michael A., Matthieu Gautier, Claudia Kathe, et al.. (2024). Single-cell and spatial atlases of spinal cord injury in the Tabulae Paralytica. Nature. 631(8019). 150–163. 34 indexed citations

Carruthers, Nicholas J., et al.. (2024). Interactions of VMAT2 with CDCrel-1 and Parkin in Methamphetamine Neurotoxicity. International Journal of Molecular Sciences. 25(23). 13070–13070.

Bernard‐Marissal, Nathalie, Cécile Hilaire, Frédérique Scamps, et al.. (2023). Differential effect of Fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth. Cellular and Molecular Biology. 69(10). 1–8. 2 indexed citations

Brown, Sharon J., Silvia A. Synowsky, Sally L. Shirran, et al.. (2023). AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice. Human Molecular Genetics. 32(20). 2950–2965. 3 indexed citations

Deguise, Marc‐Olivier, Ariane Beauvais, Simon Thebault, et al.. (2022). Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy. Gene Therapy. 29(9). 544–554. 12 indexed citations

Reimann, Regina, Marc Emmenegger, Bernard L. Schneider, et al.. (2022). Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity. Brain Pathology. 33(2). e13130–e13130. 1 indexed citations

Calò, Laura, Michał Węgrzynowicz, Jeffrey W. Dalley, et al.. (2021). CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice. Brain. 144(6). 1661–1669. 16 indexed citations

Wohlwend, Martin, Pirkka‐Pekka Laurila, Kristine Williams, et al.. (2021). The exercise-induced long noncoding RNA CYTOR promotes fast-twitch myogenesis in aging. Science Translational Medicine. 13(623). eabc7367–eabc7367. 40 indexed citations

10.

Verma, Aditi, Ajit Ray, Latha Diwakar, et al.. (2020). Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice. Movement Disorders. 35(10). 1843–1853. 9 indexed citations

11.

Colin, Philippe, et al.. (2020). Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology. Acta Neuropathologica Communications. 8(1). 198–198. 7 indexed citations

12.

Bobela, Wojciech, et al.. (2016). Spinal cord stimulation improves forelimb use in an alpha-synuclein animal model of Parkinson's disease. International Journal of Neuroscience. 127(1). 28–36. 12 indexed citations

13.

Askew, Charles, Cylia Rochat, Bifeng Pan, et al.. (2015). Tmc gene therapy restores auditory function in deaf mice. Science Translational Medicine. 7(295). 295ra108–295ra108. 205 indexed citations

14.

Colla, Emanuela, et al.. (2012). Toxic alpha-synuclein oligomer accumulation and endoplasmic reticulum stress is mechanistically linked to alpha-synucleinopathy in vivo. Molecular Biology of the Cell. 23. 1 indexed citations

15.

Colla, Emanuela, Philippe Coune, Ying Liu, et al.. (2012). Endoplasmic Reticulum Stress Is Important for the Manifestations of α-SynucleinopathyIn Vivo. Journal of Neuroscience. 32(10). 3306–3320. 315 indexed citations

16.

Schneider, Bernard L.. (2012). The End of Taxation without End: A New Tax Regime for U.S. Expatriates. SSRN Electronic Journal. 1 indexed citations

17.

Coune, Philippe, Marco Craveiro, Vladı́mir Mlynárik, et al.. (2012). An in vivo ultrahigh field 14.1 T ¹H‐MRS study on 6‐OHDA and α‐synuclein‐based rat models of Parkinson's disease: GABA as an early disease marker. NMR in Biomedicine. 26(1). 43–50. 31 indexed citations

18.

Aebischer, Patrick, et al.. (2010). Effective Delivery of the Neuroprotectant to the Brain. Movement Disorders. 25. 1 indexed citations

19.

Gamm, David M., Lynda S. Wright, Elizabeth E. Capowski, et al.. (2008). Regulation of Prenatal Human Retinal Neurosphere Growth and Cell Fate Potential by Retinal Pigment Epithelium and Mash1. Stem Cells. 26(12). 3182–3193. 28 indexed citations

20.

Lauven, P. M., et al.. (1989). Repetitive Intercostal Nerve Block via Catheter for Postoperative Pain Relief after Thoracotomy. The Thoracic and Cardiovascular Surgeon. 37(5). 273–276. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact